Bank of Montreal
PRAX icon

Bank of Montreal’s Praxis Precision Medicines PRAX Stock Holding History

Bank of Montreal’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Sell
797
-7
-0.9% -$2.22K ﹤0.01% 2842
2026
Q1 		$259K Buy
+804
New +$249K ﹤0.01% 2771
2024
Q3 		– Sell
-6,765
Closed -$285K – 4159
2024
Q2 		$285K Buy
+6,765
New +$320K ﹤0.01% 2771
2022
Q4 		– Sell
-800
Closed -$31K – 4219
2022
Q3 		$31K Buy
+800
New +$39.9K ﹤0.01% 3730
2021
Q2 		– Sell
-20
Closed -$9K – 4638
2021
Q1 		$9K Sell
20
-95
-83% -$67.5K ﹤0.01% 4416
2020
Q4 		$101K Buy
+115
New +$67.1K ﹤0.01% 3577

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Bank of Montreal's PRAX Position: Q2 2026 in Review

Bank of Montreal reduced its Praxis Precision Medicines (PRAX) stake by 0.87% in Q2 2026, selling an estimated $2.22K and leaving 797 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

Bank of Montreal first reported a position in PRAX in Q4 2020 and has held it in 6 quarters since. The position peaked at $285K in Q2 2024. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bank of Montreal held 797 shares of Praxis Precision Medicines worth $267K as of Q2 2026.
  • Bank of Montreal sold 7 Praxis Precision Medicines shares in Q2 2026, an estimated $2.22K.
  • Praxis Precision Medicines made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2842 holding.
  • Bank of Montreal first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 6 quarters since.
  • Bank of Montreal's Praxis Precision Medicines position peaked at $285K in Q2 2024.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.